TY - JOUR
T1 - Quality Management Program of Stroke Rehabilitation Using Adherence to Guidelines
T2 - A Nationwide Initiative in Japan
AU - Miura, S.
AU - Miyata, R.
AU - Matsumoto, S.
AU - Higashi, Takahiro
AU - Wakisaka, Yoshinobu
AU - Ago, Tetsuro
AU - Kitazono, Takanari
AU - Iihara, Koji
AU - Shimodozono, Megumi
N1 - Funding Information:
Funding: This work was supported by the Practical Research Project for Life-style related Diseases including Cardiovascular Diseases and Diabetes Mellitus managed by the Japan Agency for Medical Research and Development (AMED) (16ek0210046h0002; Principal Investigator: K.I., Co-Investigator: M.S.). The funder had no role in the study design, data collection and analysis, manuscript preparation, or decision to publish. Financial Disclosures: Dr. Matsumoto reports grant support from Teijin Pharma Limited. Dr. Kitazono reports speaker fees from Bayer Yakuhin Ltd. and Daiichi Sankyo Co. Ltd., consulting fees from Chugai Pharmaceutical Co. Ltd., and grant support from Takeda Pharmaceutical Co. Ltd., Daiichi Sankyo Ltd., Mitsubishi Tanabe Pharma Co., Eisai Co. Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., and MSD KK. Dr. Iihara reports grant support from AstraZeneca, Otsuka Pharmaceutical, Nihon Medi-Physics Co. Dr. Shimodozono reports lecture fee from Eli Lilly Japan K.K., and consulting fees from Yaskawa Electric Co. The remaining authors report no conflicts of interest. Funding: This work was supported by the Practical Research Project for Life-style related Diseases including Cardiovascular Diseases and Diabetes Mellitus managed by the Japan Agency for Medical Research and Development (AMED) (16ek0210046h0002; Principal Investigator: K.I., Co-Investigator: M.S.). The funder had no role in the study design, data collection and analysis, manuscript preparation, or decision to publish. We wish to thank Drs. Toshiyuki Fujiwara, Kozo Hanayama, Setsuro Ibayashi, Katsunori Ikoma, Shin-ichi Izumi, Wataru Kakuda, Ichiro Miyai, Satoru Saeki, and Shigeru Sonoda for their helpful discussions in reviewing the indicators as the expert panel. We are also grateful to the doctors who cooperated with the questionnaire survey targeting educational hospitals of the JARM. We also thank Audrey Holmes, MA, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. None. Financial Disclosures: Dr. Matsumoto reports grant support from Teijin Pharma Limited. Dr. Kitazono reports speaker fees from Bayer Yakuhin Ltd. and Daiichi Sankyo Co. Ltd., consulting fees from Chugai Pharmaceutical Co. Ltd., and grant support from Takeda Pharmaceutical Co. Ltd., Daiichi Sankyo Ltd., Mitsubishi Tanabe Pharma Co., Eisai Co. Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., and MSD KK. Dr. Iihara reports grant support from AstraZeneca, Otsuka Pharmaceutical, Nihon Medi-Physics Co. Dr. Shimodozono reports lecture fee from Eli Lilly Japan K.K., and consulting fees from Yaskawa Electric Co. The remaining authors report no conflicts of interest. Funding: This work was supported by the Practical Research Project for Life-style related Diseases including Cardiovascular Diseases and Diabetes Mellitus managed by the Japan Agency for Medical Research and Development (AMED) (16ek0210046h0002; Principal Investigator: K.I., Co-Investigator: M.S.). The funder had no role in the study design, data collection and analysis, manuscript preparation, or decision to publish.
PY - 2019/9
Y1 - 2019/9
N2 - Background and Aim: In recent years, interest in the quality of medical care has rapidly increased worldwide. However, quality indicators that contribute to establishing standard treatment in stroke medicine, especially rehabilitation, are not well-developed in Japan. Japan has established Kaifukuki (convalescent) rehabilitation wards, and the development of quality indicators for stroke rehabilitation in the convalescent phase is an urgent issue. Methods: We first reviewed the literature regarding quality indicators for stroke rehabilitation. Next, we extracted candidate indicators from identified reports and guidelines and surveyed educational hospitals certified by the Japanese Association of Rehabilitation Medicine. On the basis of the survey results, we reevaluated the suitability of the proposed indicators in discussions with an expert panel. Results: The questionnaire survey highlighted several important items that revealed there is room for improvement in adherence. For stroke rehabilitation in the convalescent phase, we adopted 15 indicators that were feasible as indicators to be used for comparisons between facilities, based on scoring by and opinions of the expert panel. These indicators measured structure (2 indicators), process (5 indicators), and outcome (8 indicators). Conclusion: This is the first study to establish quality indicators to standardize stroke rehabilitation in Japan. We developed this set of 15 indicators using an evidence-based approach. However, many tasks remain for continuous quality improvement.
AB - Background and Aim: In recent years, interest in the quality of medical care has rapidly increased worldwide. However, quality indicators that contribute to establishing standard treatment in stroke medicine, especially rehabilitation, are not well-developed in Japan. Japan has established Kaifukuki (convalescent) rehabilitation wards, and the development of quality indicators for stroke rehabilitation in the convalescent phase is an urgent issue. Methods: We first reviewed the literature regarding quality indicators for stroke rehabilitation. Next, we extracted candidate indicators from identified reports and guidelines and surveyed educational hospitals certified by the Japanese Association of Rehabilitation Medicine. On the basis of the survey results, we reevaluated the suitability of the proposed indicators in discussions with an expert panel. Results: The questionnaire survey highlighted several important items that revealed there is room for improvement in adherence. For stroke rehabilitation in the convalescent phase, we adopted 15 indicators that were feasible as indicators to be used for comparisons between facilities, based on scoring by and opinions of the expert panel. These indicators measured structure (2 indicators), process (5 indicators), and outcome (8 indicators). Conclusion: This is the first study to establish quality indicators to standardize stroke rehabilitation in Japan. We developed this set of 15 indicators using an evidence-based approach. However, many tasks remain for continuous quality improvement.
UR - http://www.scopus.com/inward/record.url?scp=85068505536&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068505536&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2019.06.028
DO - 10.1016/j.jstrokecerebrovasdis.2019.06.028
M3 - Article
C2 - 31301984
AN - SCOPUS:85068505536
SN - 1052-3057
VL - 28
SP - 2434
EP - 2441
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 9
ER -